SCA Pharmaceuticals Recalls CeFAZolin Bags Due to Sterility Concerns
SCA Pharmaceuticals is recalling 108 bags of CeFAZolin 3 g in 0.9% Sodium Chloride because the product was made with recalled saline bags that may leak, compromising sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, FDA Class II recalls involving significant injury/property-damage reports or hospitalization are Severe. While no injuries are reported, the potential for sterility failure in an IV drug is a significant risk warranting a Severe classification under the Class II criteria.
Plain-English summary
SCA Pharmaceuticals is recalling 108 bags of CeFAZolin 3 g added to 100 mL 0.9% Sodium Chloride, Total Approximate Volume 115 mL Single Dose Container bag. The product is prescription-only and was distributed nationwide in the USA. The specific lot number is 20170707@26, with a beyond-use date of 8/21/2017.
The recall was initiated due to a lack of assurance of sterility. The product was manufactured using 0.9% sodium chloride bags that were previously recalled because they have the potential to leak. This defect raises concerns about the sterility of the final drug product.
Healthcare providers and patients should stop using the affected product. The source text does not specify additional consumer actions or report any illnesses or injuries associated with this recall.
The recalled product
- Product
- ceFAZolin 3 g added to 100 mL 0.9% Sodium Chloride, Total Approximate Volume 115 mL Single Dose Container bag, Rx Only, SCA Pharmaceuticals, 8821 Knoedl Ct, Little Rock, AR 72205 (877) 550-5059; NDC: 70004-0524-32.
- Manufacturer
- SCA Pharmaceuticals
- Category
- Drug — Antibiotic
- Affected units
- 108
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 20170707@26
- BUD: 8/21/2017
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 6 recalled by SCA Pharmaceuticals under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 6 products in this recall →Related recalls
Same manufacturer · SCA Pharmaceuticals
See all →- HighSCA Pharmaceuticals Fentanyl-Bupivacaine Injectable Recall Due to Manufacturing Deviations
FDA (Drugs) · 2023-08-02
- ModerateFDA recalls Oxytocin product for low potency nationwide
FDA (Drugs) · 2023-05-03
- ModerateFentanyl Injection Syringes Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2023-03-08
- ModerateNorepinephrine Injection Recalled Nationwide for Manufacturing Quality Deviations
FDA (Drugs) · 2022-05-11
- ModerateDrug recall: fentanyl and bupivacaine injectable solution manufacturing deviations
FDA (Drugs) · 2022-05-11
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29